Shilpa Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 27-12-2024
- Paid Up Capital ₹ 1.84 Cr
as on 27-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 37.96 Cr
as on 27-12-2024
About Shilpa Therapeutics
The Corporate was formerly known as Nu Therapeutics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.84 Cr.
The company has closed loans amounting to ₹37.96 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vishnukanth Bhutada and Ramakant Innani serve as directors at the Company.
- CIN/LLPIN
U24239KA2004PTC176079
- Company No.
043005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2004
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Raichur, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shilpa Therapeutics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnukanth Bhutada  | Nominee Director | 07-Sep-2011 | Current |
| Ramakant Innani | Director | 07-Sep-2011 | Current |
Financial Performance of Shilpa Therapeutics.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shilpa Therapeutics?
Unlock access to Shilpa Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sravathi Advance Process Technologies Private LimitedActive 5 years 10 monthsVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Technologies Private LimitedActive 9 years 11 monthsVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Nuvent Paints Private LimitedActive 6 years 9 monthsVishnukanth Bhutada and Ramakant Innani are mutual person
Shilpa Biologicals Private LimitedActive 4 years 11 monthsVishnukanth Bhutada and Ramakant Innani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 16 Apr 2020 | ₹25.00 Cr | Satisfied |
Citi Bank N.A. Creation Date: 16 Apr 2020 | ₹5.00 Cr | Satisfied |
Axis Bank Limited Creation Date: 19 Dec 2016 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Shilpa Therapeutics?
Unlock and access historical data on people associated with Shilpa Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shilpa Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shilpa Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
